Cargando…

Defining COVID-19-associated hyperinflammatory syndrome in specific populations

Detalles Bibliográficos
Autor principal:	Webb, Brandon J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163291/ https://www.ncbi.nlm.nih.gov/pubmed/34095856 http://dx.doi.org/10.1016/S2665-9913(21)00157-0

Ejemplares similares

Defining the scourge of COVID-19 hyperinflammatory syndrome
por: Cron, Randy Q, et al.
Publicado: (2020)

Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study
por: Webb, Brandon J, et al.
Publicado: (2020)

Hyperinflammatory Syndrome in Children Associated With COVID-19: Need for Awareness
por: Bhat, Chandrika S., et al.
Publicado: (2020)

Aortic thrombosis in a patient with COVID-19-associated hyperinflammatory syndrome
por: Michotte, Naomi, et al.
Publicado: (2021)

Post-Infectious COVID-19-Associated Hyperinflammatory Syndrome in An Older Patient
por: Famularo, Giuseppe, et al.
Publicado: (2022)

Drugs for paediatric hyperinflammatory syndromes
por: Hon, Kam Lun, et al.
Publicado: (2022)

Haemophagocytic lymphohisticytosis—an underrecognized hyperinflammatory syndrome
por: Hutchinson, Matthew, et al.
Publicado: (2019)

Successful treatment of severe COVID-19 pneumonia and hyperinflammatory syndrome with tocilizumab
por: Gentile, Giorgio, et al.
Publicado: (2021)

How Immunosenescence and Inflammaging May Contribute to Hyperinflammatory Syndrome in COVID-19
por: Müller, Ludmila, et al.
Publicado: (2021)

COVID-19 in Children: A Review and Parallels to Other Hyperinflammatory Syndromes
por: Hobbs, Charlotte V., et al.
Publicado: (2020)

Infection-Triggered Hyperinflammatory Syndromes in Children
por: Rossano, Martina, et al.
Publicado: (2022)

COVID-19 and Hyperinflammatory Syndrome in Children: Kawasaki Disease with Macrophage Activation Syndrome in Disguise?
por: Loomba, Rohit S, et al.
Publicado: (2020)

Indigenous health-care sovereignty defines resilience to the COVID-19 pandemic
por: Petrov, Andrey N, et al.
Publicado: (2023)

EP10 Hyperinflammatory syndrome in a patient with rheumatoid arthritis and COVID-19
por: Ong, Melissa, et al.
Publicado: (2020)

Hyperinflammatory shock in children during COVID-19 pandemic
por: Riphagen, Shelley, et al.
Publicado: (2020)

Hyperinflammatory Response in COVID-19: A Systematic Review
por: Silva, Marcos Jessé Abrahão, et al.
Publicado: (2023)

Treatment of toxic epidermal necrolysis and concurrent COVID-19-associated hyperinflammatory syndrome with systemic corticosteroids and etanercept
por: Choi, Rachel, et al.
Publicado: (2022)

Spectre of COVID-19 infection confounding myocarditis related to cytomegalovirus mononucleosis syndrome and hyperinflammatory syndrome
por: Simon Frances, Blanca, et al.
Publicado: (2023)

Plasma zinc status and hyperinflammatory syndrome in hospitalized COVID-19 patients: An observational study
por: Verschelden, Gil, et al.
Publicado: (2021)

Long COVID: defining the role of rheumatology in care and research
por: Calabrese, Leonard H, et al.
Publicado: (2022)

COVID-19 and Cushing's syndrome: recommendations for a special population with endogenous glucocorticoid excess
por: Pivonello, Rosario, et al.
Publicado: (2020)

Characterization of the cytokine storm reflects hyperinflammatory endothelial dysfunction in COVID-19
por: Sims, Jonathan T., et al.
Publicado: (2021)

Clinical Characteristics of Paediatric Hyperinflammatory Syndrome in the Era of Corona Virus Disease 2019 (COVID-19)
por: Basu, Manjari, et al.
Publicado: (2021)

Effectiveness and safety of intravenous tocilizumab to treat COVID-19-associated hyperinflammatory syndrome: Covizumab-6 observational cohort()
por: Corominas, Hèctor, et al.
Publicado: (2021)

Eosinophilic pulmonary vasculitis as a manifestation of the hyperinflammatory phase of COVID-19
por: Luecke, Eva, et al.
Publicado: (2021)

Hyperinflammatory Immune Response and COVID-19: A Double Edged Sword
por: Tan, Li Yin, et al.
Publicado: (2021)

Defining the null hypothesis
por: Saxon, Emma
Publicado: (2015)

Physiological and biological heterogeneity in COVID-19-associated acute respiratory distress syndrome
por: Ware, Lorraine B
Publicado: (2020)

Gastrointestinal post-acute COVID-19 syndrome
por: Meringer, Hadar, et al.
Publicado: (2022)

COVID-19 and Down syndrome: the spark in the fuel
por: Majithia, Manini, et al.
Publicado: (2022)

Drug‐resistant seizures associated with hyperinflammatory monocytes in FIRES
por: Howe, Charles L., et al.
Publicado: (2023)

Corticosteroid Therapy Is Associated With Improved Outcome in Critically Ill Patients With COVID-19 With Hyperinflammatory Phenotype
por: Chen, Hui, et al.
Publicado: (2021)

O03 A case of hyperinflammatory COVID-19 that responded to tocilizumab therapy
por: Biddle, Kathryn, et al.
Publicado: (2020)

A Novel Strategy to Mitigate the Hyperinflammatory Response to COVID-19 by Targeting Leukotrienes
por: Funk, Colin D., et al.
Publicado: (2020)

Triple immune modulator therapy for aberrant hyperinflammatory responses in severe COVID-19
por: Koh, June-Young, et al.
Publicado: (2023)

Commentary: Intersectional perspectives on COVID-19 exposure
por: Sasser, Jade S., et al.
Publicado: (2021)

Multi-omic approach to identify risk markers specific to COVID-19
por: Kim, Won-Young
Publicado: (2022)

COVID-19 in axial spondyloarthritis care provision: helping to straighten the long and winding road
por: Marzo-Ortega, Helena, et al.
Publicado: (2021)

Treatment for severe acute respiratory distress syndrome from COVID-19
por: Matthay, Michael A, et al.
Publicado: (2020)

Cats and kids: how a feline disease may help us unravel COVID-19 associated paediatric hyperinflammatory syndrome
por: Alberer, Martin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9jliqdfocp9b3q1ej27kcn2ksv